Back
Intra-Cellular Therapies Vs. ACADIA Pharmaceuticals Industry Stock Comparison
Sell
38
ITCI
Intra-Cellular Therapies
Last Price:
77.09
Seasonality Move:
27.94%
Sell
35
ACAD
ACADIA Pharmaceuticals
Last Price:
14.50
Seasonality Move:
11.95%
Sell
38
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $77.09. The Score for ITCI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
ACADIA Pharmaceuticals (ACAD)
is a Sell
Is ACADIA Pharmaceuticals a Buy, Sell or Hold?
- The current ACADIA Pharmaceuticals [ACAD] share price is $14.52. The Score for ACAD is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- ACAD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $77.09
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight selling pressure.
ACAD Stock Price Chart
What is ACADIA Pharmaceuticals's stock price today?
-
The ACADIA Pharmaceuticals share price today is $14.52
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACAD is experiencing selling pressure, which indicates risk of future bearish movement.
ITCI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.64 | Buy |
Relative Strength Index (14 RSI): | 58.08 | Buy |
Chaikin Money Flow: | -3459 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (72.66 - 76.4) | Buy |
Bollinger Bands (100): | (70.6 - 77.3) | Buy |
ACAD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.3 | Sell |
Relative Strength Index (14 RSI): | 38.36 | Sell |
Chaikin Money Flow: | -682250 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.66 - 15.94) | Sell |
Bollinger Bands (100): | (14.86 - 17.38) | Sell |
ITCI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 75.79 | Buy |
20-day SMA: | 74.15 | Buy |
50-day SMA: | 74.47 | Buy |
200-day SMA: | 71.38 | Buy |
8-day EMA: | 75.95 | Buy |
20-day EMA: | 74.93 | Buy |
50-day EMA: | 74.5 | Buy |
200-day EMA: | 70.77 | Buy |
ACAD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.87 | Sell |
20-day SMA: | 15.04 | Sell |
50-day SMA: | 15.6 | Sell |
200-day SMA: | 18.64 | Sell |
8-day EMA: | 14.86 | Sell |
20-day EMA: | 15.1 | Sell |
50-day EMA: | 15.62 | Sell |
200-day EMA: | 17.99 | Sell |
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.96 per share, and an increase next year of $1.12 per share.
ACADIA Pharmaceuticals Earnings Growth & ACAD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.84 per share, and an increase next year of $0.29 per share.
Intra-Cellular Therapies Technical Analysis
Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ACADIA Pharmaceuticals Technical Analysis
Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |